logo-loader
viewMedlab Clinical Ltd

Medlab launches online clinical service for consultations with doctors

Medlab has developed the virtual clinic so that anyone can have access to a free, no-obligation, 10-minute confidential consultation via any computer or smart device with internet access.

Medlab Clinical Ltd - Medlab announces online clinical services for consultations with doctors
Clinic appointments are available online

Medlab Clinical Ltd (ASX:MDC) has launched telehealth initiatives to minimise the potential impact of the COVID-19 virus.

It is a unique, online clinical service that offers advice and connects the Australian public to doctors, specialists, naturopaths and pharmacists.

Using disruptive technology, ‘the Clinic’ offers free 10-minute consultations via online bookings and video conferencing and can be accessed via https://clinic.medlab.co.

Smartphone scheduling

Medlab understands that people are time-poor, in remote locations or simply not always able to visit their healthcare practitioner but have access to digital technology.

Medlab chief executive officer Dr Sean Hall said: “Remember house calls, this is the next best thing, a potential patient can use their smart phone to schedule and connect to a holistic healthcare provider, at no cost whilst ensuring medical standards such as education and confidentiality are kept.

“Considering the current global events, this service is timely, whilst these practitioners are not here to diagnosis or treat COVID-19 they are well placed to offer free advice of hygiene, health and more important, simple things people can do to strengthen their immunity.”

The Clinic is for people who are seeking advice on how nutraceuticals may be used for supportive health/medical care.

High standards in place

Medlab’s complementary healthcare practitioners are educated and audited by the company’s medical team to ensure a standard of care, confidentiality and ongoing training consistent with other healthcare professionals, this includes offering unbiased advice.

Planning for changing conditions

To date, no Medlab employee has tested positive for COVID-19, and the company remains vigilant and ready to respond to conditions or government guidance as required.

All company resources are in a secure cloud allowing all staff with appropriate authentication to access their work and collaborate with their teams.

In the event of office closure due to COVID-19, the staff are well placed to continue working from home.

Expectations around supply chain across the business are to remain open but there may be short term delays in manufacturing for some products.

Quick facts: Medlab Clinical Ltd

Price: 0.19 AUD

ASX:MDC
Market: ASX
Market Cap: $44.31 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Medlab Clinical Ltd named herein, including the promotion by the Company of Medlab Clinical Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Medlab Clinical forges ahead in new vitamin trials for chronic illnesses

Medlab Clinical Ltd (ASX:MDC) chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist those with chronic health conditions.   Hall says there has been a shortfall in the standard of...

on 8/5/19

2 min read